AlisaEKochMDPh.D. (honaris causa)
Rheumatology • Ann Arbor, MISr. Medical Fellow, Eli Lilly and Company
Dr. Koch is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 East Medical Center Dr
3RD floor Taubman CTR Recp A
Ann Arbor, MI 48109Phone+1 734-647-5900
Education & Training
McGaw Medical Center of Northwestern UniversityFellowship, Rheumatology, 1984 - 1986
Loyola University Medical CenterResidency, Internal Medicine, 1980 - 1983- Northwestern University The Feinberg School of MedicineClass of 1980
Certifications & Licensure
MI State Medical License 2003 - 2025
CA State Medical License 1985 - 2017
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1994
- Fellow (FACR) American College of Rheumatology
Clinical Trials
- Angiogenic/Angiostatic Mediators in Patients With Systemic Sclerosis Start of enrollment: 2007 May 01
Publications & Presentations
PubMed
- Neutrophil Activation Markers and Rheumatoid Arthritis Treatment Response to the JAK1/2 Inhibitor Baricitinib.Runa Kuley, Bhargavi Duvvuri, Sabeeha Hasnain, Ernst R Dow, Alisa E Koch
Arthritis & Rheumatology. 2024-10-21 - 1 citationsMammalian Glycosylation Patterns Protect Citrullinated Chemokine MCP-1/CCL2 from Partial Degradation.Olexandr Korchynskyi, Ken Yoshida, Nataliia Korchynska, Justyna Czarnik-Kwaśniak, Paul P Tak
International Journal of Molecular Sciences. 2023-01-18 - 23 citationsMechanism of action of baricitinib and identification of biomarkers and key immune pathways in patients with active systemic lupus erythematosus.Thomas Dörner, Yoshiya Tanaka, Ernst R Dow, Alisa E Koch, Maria Silk
Annals of the Rheumatic Diseases. 2022-08-11
Other
- Synovial pathology in rheumatoid arthritisKoch AE
http://www.uptodate.com/contents/synovial-pathology-in-rheumatoid-arthritis
UpToDate, Wolters Kluwer Health - 2012-12-11
Grant Support
- Fucosyl Transferases In Inflammation And AngiogenesisVeterans Affairs2011–2012
- IL-18 In Rheumatoid Inflammation And AngiogenesisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2003–2007
- IL-4 And IL-13 Gene Therapy For ArthritisNational Institute Of Allergy And Infectious Diseases2003–2006
- Novel Angiogenic Cytokine Induced Endothelial AntigenNational Heart, Lung, And Blood Institute2002
- Novel Angiogenic Cytokine Induced Endothelial AntigenNational Heart, Lung, And Blood Institute1999–2002
- IL 4 And IL 13 Gene Therapy For ArthritisNational Institute Of Allergy And Infectious Diseases1998–2001
- IL 4 And IL 13 Gene Therapy For ArthritisNational Institute Of Allergy And Infectious Diseases1997
- GRO Alpha And ArthritisFogarty International Center1996
- Chemotactic Cytokines In Rheumatoid ArthritisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1992–1996
- Feasibility Study--Monocyte/Macrophage Heterogeneity In Rheumatoid ArthrisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1987–1991
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
